1992 Volume 45 Issue 6 Pages 734-737
Meropenem (MEPM) was evaluated for its efficacy and safety. The following results were obtained.
MEPM was given to 12 patients with infections: 5 with pneumonia, 1 with bacterial meningitis, 2 with pharyngitis, 4 with skin and soft tissue infections. Therapeutic responses were excellent in 5, good in 4 and fair in 3, with an efficacy rate of 75%.
Adverse reactions were not noted. No abnormalities were shown in laboratory data.
It has been concluded that MEPM is a useful drug for the treatment of bacterial infections in children.